ACHN
{"sector":"Healthcare","industry":"Drugs","symbol":"ACHN","company_name":"ACHILLION PHARMACEUTICALS, INC...","exchange":"NASDAQ"}ACHN Articles
Achillion Pharmaceuticals shares skyrocketed on Wednesday morning on news that the firm would be acquired by Alexion Pharmaceuticals.
Published:
Last Updated:
Achillion Pharma shares jumped on Wednesday after the firm announced that the FDA has granted Breakthrough Therapy designation for danicopan (ACH-4471).
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included American Express, Bristol-Myers Squibb, Celgene, CognizantTechnology Solutions, Electronic Arts, Fortinet, Lyft, Target,...
Published:
Last Updated:
TrovaGene, Range Resources, Achillion Pharma, and Colony NorthStar all posted new 52-week lows on Friday.
Published:
Last Updated:
Achillion Pharmaceuticals saw its shares make a handy gain on Thursday after the company announced a secondary offering.
Published:
Last Updated:
Achillion Pharmaceuticals saw its shares slump early on Monday after the firm announced that its hepatitis C license and collaboration agreement with Janssen had been terminated.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Cisco, Expedia, Exxon, First Solar, Noble, Shake Shack and Symantec.
Published:
Last Updated:
24/7 Wall Street takes a look at Facebook and a few other companies posting some of the largest losses for the past week.
Published:
Last Updated:
Cult stocks can fall from grace rather quickly — even if they haven't been in the good grace of the trading gods for some time.
Published:
Last Updated:
The week of September 23 brought numerous analyst upgrades and downgrades in the biotech and biohealth space.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday morning include Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart and Yum Brands.
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.
Published:
Last Updated:
Here are five stocks trading under $10 with massive analyst upside targets from the week of July 1.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Bank of America, First Solar, KKR, On Deck Capital, Red Hat and Shake Shack.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen from Friday, February 26, include American Water Works, Autodesk, Kraft Heinz, Palo Alto Networks, Toyota and Vipshop.
Published:
Last Updated: